What is the treatment for conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis

For bacterial conjunctivitis, topical antibiotics such as ofloxacin are recommended with a regimen of one to two drops every 2-4 hours for days 1-2, then four times daily for days 3-7. 1

Diagnosis and Treatment Approach by Type

Bacterial Conjunctivitis

  • Clinical presentation: Mucopurulent discharge, mattering and adherence of eyelids upon waking, lack of itching 2, 3
  • Common pathogens: Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus epidermidis, and Moraxella species 1, 4
  • Treatment:
    1. Topical antibiotics (first-line options):
      • Ofloxacin: 1-2 drops every 2-4 hours for days 1-2, then 1-2 drops four times daily for days 3-7 1
      • Other options: Gentamicin, tetracycline, moxifloxacin 0.5% 5
    2. Duration: Standard treatment course is 5-7 days, continuing until resolution of discharge, no more mattering of eyelids in the morning, and reduction in conjunctival injection 5
    3. Most cases improve within 1-3 days of appropriate antibiotic therapy 5

Viral Conjunctivitis

  • Clinical presentation: Watery discharge, often unilateral that becomes bilateral, possible lymphadenopathy 3
  • Treatment:
    • Supportive care with artificial tears and cold compresses 3
    • No antibiotics needed as they are ineffective against viral causes 2
    • Patient isolation for 10-14 days from symptom onset to prevent spread 5

Allergic Conjunctivitis

  • Clinical presentation: Bilateral itching (most consistent sign), watery discharge, seasonal patterns 2, 3
  • Treatment:
    • Topical antihistamines with mast cell-stabilizing activity 3
    • Avoidance of allergens when possible 2

Special Considerations

Neonatal Conjunctivitis

  • Requires urgent evaluation and treatment due to risk of serious complications
  • For suspected gonococcal conjunctivitis:
    • BOTH systemic (ceftriaxone) AND topical antibiotic therapy 5
    • Collect specimens before starting treatment 5
  • For suspected chlamydial conjunctivitis:
    • Systemic therapy with azithromycin, doxycycline, or levofloxacin 5
    • Topical therapy alone is inadequate 5
  • Evaluate and treat the mother and her sexual partner(s) 5

When to Refer to Ophthalmology

  • Lack of response to therapy after 3-4 days
  • Moderate to severe pain
  • Decreased vision
  • Corneal involvement
  • Conjunctival scarring
  • Recurrent episodes
  • History of herpes simplex virus eye disease
  • Immunocompromised patients
  • Suspected herpetic conjunctivitis (vesicular lesions, corneal involvement) 5, 3

Evidence on Treatment Efficacy

Research demonstrates that topical antibiotics significantly accelerate recovery from bacterial conjunctivitis. A meta-analysis showed that antibiotics improved early (days 2-5) clinical remission rates (RR 1.36,95% CI 1.15 to 1.61) and microbiological remission rates (RR 1.55,95% CI 1.37 to 1.76) 6. Even at later time points (days 6-10), antibiotics still conferred modest benefits in clinical remission (RR 1.21,95% CI 1.10 to 1.33) 6.

A randomized controlled trial in children showed that by 3-5 days, 62% of patients receiving topical antibiotics were clinically cured compared to only 28% in the placebo group (P < 0.02) 7.

Prevention of Spread

  • Frequent handwashing
  • Avoid sharing towels and pillowcases
  • Proper contact lens care 5
  • Patients with bacterial conjunctivitis can typically return to work or school after 24 hours of antibiotic treatment 5

Important Caveats

  1. Antibiotic resistance concerns: Increasing resistance to fluoroquinolones has been reported, particularly in MRSA isolates. Consider local resistance patterns when selecting antibiotics 5, 4.

  2. Self-limiting nature: While bacterial conjunctivitis is often self-limiting (41% of placebo cases resolve by days 6-10) 6, antibiotics speed recovery and reduce transmission risk.

  3. Delayed prescribing: For mild cases, delayed antibiotic prescribing may be considered, as it has similar symptom control as immediate prescribing 5, 3.

  4. Conjunctivitis secondary to STDs: Cases due to gonorrhea or chlamydia require systemic treatment in addition to topical therapy 2.

  5. Contact lens wearers: These patients should always receive antibiotic treatment due to higher risk of complications 3.

References

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Guideline

Neonatal Conjunctivitis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotics versus placebo for acute bacterial conjunctivitis.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.